Publications by authors named "James Aries"

Claim this Profile
V
Venetoclax-based non-intensive combinations for relapsed/refractory acute myeloid leukaemia-Real-world data from a UK-wide programme.
Henry Wood, Jenny O'Nions, Wei Yee Chan, Albert Borg, Scott Veitch, James Aries

Br J Haematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax-based low intensity therapy in molecular failure of NPM1-mutated AML.
Carlos Jimenez-Chillon, Jad Othman, David Taussig, Carlos Jimenez-Vicente, Alexandra Martinez-Roca, James Aries

Blood Adv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML.
Jad Othman, Nicola Potter, Katya Mokretar, David Taussig, Anjum Khan, James Aries

Leukemia· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cessation of Ciprofloxacin Prophylaxis in Hemato-Oncology Patients.
Louise Caldwell, Anjaneya Bapat, Lydia N Drumright, Jonathan Lambourne, Fergus G Jimenez-England, James Aries

Clin Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2022 update on the clinical outcome of coronavirus disease 2019 in haemato-oncology patients.
Susie Bradwell, Luke Hone, Kirstie Thorneycroft, Jonathan Lambourne, James A Aries

Leuk Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy.
Stephen Booth, Helen M Curley, Csilla Varnai, Roland Arnold, Lennard Y W Lee, James Aries

Br J Haematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high-risk myeloma patients - a single centre experience.
Amanda Jurgensen-Rauch, Suzanne Gibbs, Maresa Farrell, James Aries, Marianne Grantham

Br J Haematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinoic acid-responsive CD8 effector T cells are selectively increased in IL-23-rich tissue in gastrointestinal GVHD.
Jennifer A Ball, Andrew Clear, James Aries, Sarah Charrot, Caroline Besley

Blood· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcome of coronavirus disease 2019 in haemato-oncology patients.
James A Aries, Jeffrey K Davies, Rebecca L Auer, Simon L Hallam, Silvia Montoto

Br J Haematol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing HIV and Hodgkin lymphoma in the twenty-first century.
James Aries, Silvia Montoto

Curr Hematol Malig Rep· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonconvulsive status epilepticus and leucoencephalopathy after high-dose methotrexate.
Daniel M Patterson, James Aries, Harpreet Hyare, David Holder, Jeremy Rees

J Clin Oncol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis